Cell defence

GlyNAC

Glycine + N-acetylcysteine

Central packet question: glutathione + physical function in older adultsEvidence level C

Level C describes limited, mixed or context-dependent human evidence for this exact question; read the conclusion for direction and limits.

This C grade applies only to the controlling packet's central question of glutathione plus physical function in older adults. Cognition is evidence level D, healthy-aging and lifespan claims are evidence level E, and no grade transfers to glycine alone, NAC alone, another formula or a finished product.

IN PLAIN LANGUAGE

Why people are interested

GlyNAC combines glycine and NAC, two substrates used to make glutathione. One very small longer trial was encouraging, but a larger short trial missed its main whole-blood glutathione result.

Outcome map

One ingredient. Different questions.

Evidence can be stronger for a specific marker or population and weaker for a broader promise. Each row answers a separate question.

01
Glutathione synthesis mechanism
Glycine and cysteine are used in glutathione synthesis, but established biochemistry does not guarantee a clinical benefit.
Evidence level A
02
Selected low-GSH older adults
One very small 16-week trial increased muscle and red-cell glutathione in a selected group, without independent replication.
Evidence level B
03
Whole-blood glutathione
A larger 14-day trial in generally healthy older adults was null on its prespecified whole-blood glutathione endpoint.
Evidence level C
04
Physical function
Preliminary signals come from one small trial not powered for function and an uncontrolled pilot, without replicated disability outcomes.
Evidence level C
05
Cognition
Cognitive evidence rests on an eight-person uncontrolled pilot and does not establish a reliable benefit or prevention effect.
Evidence level D
06
Healthy aging and lifespan
No human trial establishes disease prevention, slower biological aging, longer healthspan or longer life from GlyNAC.
Evidence level E

Library trackIngredient review

Last reviewed22 Aug 2026

Guide scopeIngredient research only

How it may work

Combines glycine and N-acetylcysteine, two substrates used in glutathione synthesis; mechanism does not establish a clinical outcome.

What people have studied

GlyNAC has early, mixed human evidence. One very small 16-week randomized trial in selected older adults increased muscle and red-cell glutathione and generated preliminary physical-function signals, but a larger 14-day trial in generally healthy older adults was null on its prespecified whole-blood glutathione endpoint. Cognition rests on an eight-person uncontrolled pilot, and no human trial establishes disease prevention, slower aging or longer life.

What to consider

Short, selected studies cannot establish universal or long-term safety. Evidence for glycine or NAC alone does not automatically transfer to their combination, and NAC has medicine, route and medical-context considerations.

Local pathway

The exact ingredient combination, strength, format and claims require specialist local classification before commercialization.

Sources + indexes

See where the explanation comes from.

Open the linked research and official records behind this guide. Early topics may begin with a research index while stronger sources are added.